专利检索 ap:("Korea Research Institute of Bioscience AND Biotechnology") AND inv:"KHIEV, Piseth" 第 1 页

1.

发明授权
INGENANE-TYPE DITERPENE COMPOUND, AND PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING VIRAL INFECTIOUS DISEASES 有权

公开(公告)号：EP2769973B1

公开(公告)日：2018-09-12

申请号：EP12841496.8

申请日：2012-09-28

申请人： Korea Research Institute of Bioscience and Biotechnology

发明人： OH, Sei Ryang , KIM, Jae Wha , LEE, Hyeong Kyu , KHIEV, Piseth , KIM, Doo Young , KIM, Jung Hee , SONG, Jae Sung , AHN, Kyung Seop

IPC分类号： C07C69/716 , C07C69/013 , A61P31/12 , A61K31/22

CPC分类号： C07C69/33 , A23L33/10 , A23L33/12 , A61K31/22 , A61K31/23 , A61K36/47 , C07C2603/30

摘要： The present invention relates to an injenane-type diterpene compound derived from Euphorbia kansui Liou, and a pharmaceutical composition for treating or preventing viral infectious diseases, a health functional food for preventing or ameliorating viral infectious diseases and a composition for enhancing the production of interferon-gamma, which comprise the injenane-type diterpene compound. Furthermore, the present invention relates to a method for preventing or treating viral infectious diseases including administering the composition to a subject having a viral infectious disease occurrence or a risk thereof with a therapeutically effective dose.

2.

发明公开
INGENANE-TYPE DITERPENE COMPOUND, AND PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING VIRAL INFECTIOUS DISEASES CONTAINING SAME 审中-公开
标题翻译：用于治疗或预防病毒感染疾病Ingenane二萜类化合物和药物组合物

公开(公告)号：EP2769973A2

公开(公告)日：2014-08-27

申请号：EP12841496.8

申请日：2012-09-28

申请人： Korea Research Institute of Bioscience and Biotechnology

发明人： OH, Sei Ryang , KIM, Jae Wha , LEE, Hyeong Kyu , KHIEV, Piseth , KIM, Doo Young , KIM, Jung Hee , SONG, Jae Sung , AHN, Kyung Seop

IPC分类号： C07C69/716 , C07C69/013 , A61P31/12 , A61K31/22

CPC分类号： C07C69/33 , A23L33/10 , A23L33/12 , A61K31/22 , A61K31/23 , A61K36/47 , C07C2603/30

摘要： The present invention relates to an injenane-type diterpene compound derived from Euphorbia kansui Liou, and a pharmaceutical composition for treating or preventing viral infectious diseases, a health functional food for preventing or ameliorating viral infectious diseases and a composition for enhancing the production of interferon-gamma, which comprise the injenane-type diterpene compound. Furthermore, the present invention relates to a method for preventing or treating viral infectious diseases including administering the composition to a subject having a viral infectious disease occurrence or a risk thereof with a therapeutically effective dose.